3 ms·

So, the point of this is to reduce competition from smaller companies?

• Clubber 7y ago
  Expensive regulation usually benefits the organizations that can afford it to the detriment of those that can't. Regulation is certainly a two edge sword in this regard. I'm left to wonder if this is an intended or unintended consequence. A British study recently came out finding eCigarettes 95% less harmful than cigarettes. https://www.theguardian.com/society/2018/dec/28/vaping-is-95-safer-than-smoking-claims-public-health-england https://www.theguardian.com/society/2018/dec/28/vaping-is-95...
  • lotsofpulp 7y ago
    Large scale health studies are going to cost a lot of money since they use up a tremendous amount of human time and resources in short supply. If we want the data, we have to pay for it. One option is to pay for it with tax dollars (which already happens).
• atlasunshrugged 7y ago
  I think the point is to make sure that no one dies or is hurt - the FDA takes a very strong view on preventing injury and death, not always weighting the opposite side of the coin of people who are already dying or being hurt (ex. taking years to approve drugs that have a high likelihood of helping more people than they hurt, but not doing so until being as close to totally sure as possible to try to prevent new deaths/injury)
  • Mirioron 7y ago
    Basically, what you're saying is that the FDA likes keeping their jobs, because the only thing that can threaten them is them screwing up. It doesn't matter if approval is expensive or takes a long time, because they have no competition or incentive to do better.